4.6 Article

Human Herpesvirus 6A Partially Suppresses Functional Properties of DC without Viral Replication

Journal

PLOS ONE
Volume 8, Issue 3, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0058122

Keywords

-

Funding

  1. Board of Doctoral Education at Karolinska Institutet [4769/07-225]
  2. Swedish Association for Persons with Neurological Disabilities
  3. Swedish Dental Society
  4. BiogenIdec
  5. Merck Serono
  6. Sanofi-Aventis
  7. Swedish Research Council
  8. KI Funds [2008Fobi0783]
  9. IMI-grant (ABIRISK project)

Ask authors/readers for more resources

Human herpesvirus 6A (HHV-6A) is a common virus with a worldwide distribution that has been associated with multiple sclerosis. Whether HHV-6A can replicate in dendritic cells (DC) and how the infection might modulate the functional properties of the cell are currently not well known and need further investigations. Here, we show that a non-productive infection of HHV-6A in DC leads to the up-regulation of HLA-ABC, via autocrine IFN-alpha signaling, as well as the up-regulation of HLA-DR and CD86. However, HHV-6A exposure reduces IL-8 secretion by DC and their capacity to stimulate allogenic T cell proliferation. The ability to suppress DC functions important for activation of innate and adaptive immune responses might be one successful strategy by which HHV-6A avoids the induction of appropriate host defense mechanisms, and thus facilitating persistent infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Hematology

Response to mitogen-activated protein kinase inhibition of neurodegeneration in Langerhans cell histiocytosis monitored by cerebrospinal fluid neurofilament light as a biomarker: a pilot study

Jan-Inge Henter, Egle Kvedaraite, Daniel Martin Munoz, Monica Cheng Munthe-Kaas, Bernward Zeller, Tove A. Nystad, Caroline Bjorklund, Isabella Donner, Magda Lourda, Henrik Zetterberg, Kaj Blennow, Nikolas Herold, Desiree Gavhed, Tatiana von Bahr Greenwood

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Article Immunology

COVID-19-specific metabolic imprint yields insights into multiorgan system perturbations

Martin Cornillet, Benedikt Strunz, Olav Rooyackers, Andrea Ponzetta, Puran Chen, Jagadeeswara Rao Muvva, Mira Akber, Marcus Buggert, Benedict J. Chambers, Majda Dzidic, Iva Filipovic, Jean-Baptiste Gorin, Sara Gredmark-Russ, Laura Hertwig, Jonas Klingstrom, Efthymia Kokkinou, Egle Kvedaraite, Magda Lourda, Jenny Mjosberg, Christopher Maucourant, Anna Norrby-Teglund, Tiphaine Parrot, Andre Perez-Potti, Olga Rivera-Ballesteros, Johan K. Sandberg, John Tyler Sandberg, Takuya Sekine, Mattias Svensson, Renata Varnaite, Lars Eriksson, Soo Aleman, Kristoffer Stralin, Hans-Gustaf Ljunggren, Niklas K. Bjorkstrom

Summary: An in-depth assessment of 1129 unique metabolites in 27 hospitalized COVID-19 patients revealed a COVID-19-specific metabolic imprint. Following severe acute respiratory syndrome coronavirus-2 seroconversion, the metabolic response underwent a switch, indicating a network of metabolic trajectories aligned with immune activation pathways and organ damage.

EUROPEAN JOURNAL OF IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection

Sebastian Havervall, August Jernbom Falk, Jonas Klingstrom, Henry Ng, Nina Greilert-Norin, Lena Gabrielsson, Ann-Christin Salomonsson, Eva Isaksson, Ann-Sofie Rudberg, Cecilia Hellstrom, Eni Andersson, Jennie Olofsson, Lovisa Skoglund, Jamil Yousef, Elisa Pin, Wanda Christ, Mikaela Olausson, My Hedhammar, Hanna Tegel, Sara Mangsbo, Mia Phillipson, Anna Manberg, Sophia Hober, Peter Nilsson, Charlotte Thalin

Summary: Current serological assays for SARS-CoV-2 generate inconsistent results and the longitudinal characteristics of antibodies targeting different antigens after asymptomatic or mild COVID-19 have not been established. This cohort study involving healthcare workers found that antibodies against the SARS-CoV-2 spike antigen remained detectable in 96% of participants at least four months after infection, even if they had no or mild symptoms. The study also confirmed virus neutralization capacity in 91% of participants at least four months after infection.

PLOS ONE (2022)

Letter Hematology

Mutation in the TACI gene and autoimmune neutropenia: A case report

Peter Bergman, Per-Anders Broliden, Paul Ratcliffe, Magda Lourda, Brigitte Flesch, Petter Hoglund, Jan Palmblad

AMERICAN JOURNAL OF HEMATOLOGY (2022)

Article Hematology

Screening for neurodegeneration in Langerhans cell histiocytosis with neurofilament light in plasma

Malin Sveijer, Tatiana von Bahr Greenwood, Martin Jadersten, Egle Kvedaraite, Henrik Zetterberg, Kaj Blennow, Magda Lourda, Desiree Gavhed, Jan-Inge Henter

Summary: This study compared levels of NFL in plasma and cerebrospinal fluid of patients with LCH, suggesting that p-NFL may be used for screening of ND-CNS-LCH. Further research is encouraged to explore the role of p-NFL in monitoring ND-CNS-LCH.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Article Multidisciplinary Sciences

Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination

Chengzi Kaku, Elizabeth R. Champney, Johan Normark, Marina Garcia, Carl E. Johnson, Clas Ahlm, Wanda Christ, Mrunal Sakharkar, Margaret E. Ackerman, Jonas Klingstrom, Mattias N. E. Forsell, Laura M. Walker

Summary: Heterologous prime-boost immunization strategies have the potential to enhance the efficacy of COVID-19 vaccines. A study found that heterologous vaccination induced stronger neutralizing antibody and memory B cell responses, as well as better efficacy against variant strains. The study also revealed that heterologous vaccination can enhance the quality of B cell responses.

SCIENCE (2022)

Article Immunology

Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines

Ulrika Marking, Sebastian Havervall, Nina Greilert-Norin, Henry Ng, Kim Blom, Peter Nilsson, Mia Phillipson, Sophia Hober, Charlotta Nilsson, Sara Mangsbo, Wanda Christ, Jonas Klingstrom, Max Gordon, Mikael Aberg, Charlotte Thalin

Summary: Heterologous primary SARS-CoV-2 vaccination with ChAd and BNT elicits a stronger initial immune response compared to homologous vaccination with ChAd, particularly in terms of antibody response. However, although the differences in humoral responses remain over 6 months, the difference in SARS-CoV-2 specific T cell responses are no longer significant three months after vaccination.

VACCINES (2022)

Letter Medicine, General & Internal

Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection

Sebastian Havervall, Ulrika Marking, Julia Svensson, Nina Greilert-Norin, Philip Bacchus, Peter Nilsson, Sophia Hober, Max Gordon, Kim Blom, Jonas Klingstrom, Mikael Aberg, Anna Smed-Sorensen, Charlotte Thalin

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Letter Dermatology

Baricitinib Blocks Cytokine-Mediated Downregulation of PAD1 in Human Keratinocytes: A Possible Molecular Link to the Effects of JAK Inhibitors in Atopic Dermatitis

Avinash Padhi, Sultana Rekha, Lisa Benrejdal, Marijke Elise Grundeken, Magda Lourda, Marcus Ehrstrom, Kilian Eyerich, Isabel Tapia Paez, Emma K. Johansson, Maria Bradley, Peter Bergman, Josefin Lysell

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2023)

Editorial Material Virology

Pending Reorganization of Hantaviridae to Include Only Completely Sequenced Viruses: A Call to Action

Jens H. Kuhn, Steven B. Bradfute, Charles H. Calisher, Boris Klempa, Jonas Klingstrom, Lies Laenen, Gustavo Palacios, Connie S. Schmaljohn, Nicole D. Tischler, Piet Maes

Summary: The official classification of viruses by the ICTV requires complete or nearly complete genome sequences to be deposited in GenBank. This requirement is fairly new, resulting in fragmented or absent genomic sequence information for many classified viruses. This poses challenges for taxon-wide phylogenetic analyses, especially for viruses with segmented genomes. To address this issue for Hantaviridae, the community is urged to provide additional sequence information for incompletely sequenced classified viruses by mid-June 2023 to prevent possible declassification.

VIRUSES-BASEL (2023)

Article Multidisciplinary Sciences

Interplay between human STING genotype and bacterial NADase activity regulates inter-individual disease variability

Elin Movert, Jaume Salgado Bolarin, Christine Valfridsson, Jorge Velarde, Steinar Skrede, Michael Nekludov, Ole Hyldegaard, Per Arnell, Mattias Svensson, Anna Norrby-Teglund, Kyu Hong Cho, Eran Elhaik, Michael R. Wessels, Lars Raberg, Fredric Carlsson

Summary: The severity of diseases caused by microbial pathogens can vary due to the unique combination of host and pathogen genomes in each infection. In a study on invasive Streptococcus pyogenes infection, researchers found that the outcome is regulated by the interaction between human STING genotype and bacterial NADase activity. The activity of NADase variants expressed by invasive strains suppresses the production of type I interferon mediated by STING.

NATURE COMMUNICATIONS (2023)

Letter Health Care Sciences & Services

Point prevalence of SARS-CoV-2 infection among healthcare workers in March and June 2023 in Sweden

Kim Blom, Oscar Bladh, Sebastian Havervall, Ulrika Marking, Nina Greilert Norin, Jessica J. Alm, Jonas Klingstrom, Charlotte Thalin

LANCET REGIONAL HEALTH-EUROPE (2023)

Article Virology

SARS-CoV-2 variant-specific differences in inhibiting the effects of the PKR-activated integrated stress response

Wanda Christ, Jonas Klingstrom, Janne Tynell

Summary: The integrated stress response (ISR) is activated in response to SARS-CoV-2 infection, triggering translational arrest and inhibiting stress granule formation. However, the stress-responsive transcription factors ATF4 and CHOP are not induced. Different SARS-CoV-2 variants show variant-specific differences in ISR activation, suggesting potential impacts on pathogenesis and treatment strategies.

VIRUS RESEARCH (2024)

Meeting Abstract Oncology

Response to Mapk Inhibition of Neurodegeneration in Lch Monitored by Csf Neurofilament Light as a Biomarker

Jan-Inge Henter, Egle Kvedaraite, Daniel Martin Munoz, Monica Cheng Munthe-Kaas, Bernward Zeller, Tove Nystad, Caroline Bjorklund, Isabella Donner, Magda Lourda, Henrik Zetterberg, Kaj Blennow, Nikolas Herold, Desiree Gavhed, Tatiana von Bahr Greenwood

PEDIATRIC BLOOD & CANCER (2022)

Meeting Abstract Oncology

Plasma Signalling Factors in patients with Langerhans Cell Histiocytosis (Lch) Correlate with Relative Frequencies of Lch cells and T cells within Lesions

Jenee Mitchell, Egle Kvedaraite, Tatiana von Bahr Greenwood, Magda Lourda, Jan-Inge Henter, Stuart Berzins, George Kannourakis

PEDIATRIC BLOOD & CANCER (2022)

No Data Available